Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.


TSX:DC.A - Post by User

Post by Catscratchon Jan 18, 2024 12:54pm
230 Views
Post# 35833940

TauRx Update: HMTM Hong Kong and Macau

TauRx Update: HMTM Hong Kong and MacauAn update from TauRx...

https://www.macaubusiness.com/poredeen-appoints-icb-as-exclusive-named-patient-program-manager-for-hmtm-in-hong-kong-and-macau/

"In the United Kingdom, TauRx is actively pursuing approval from the Medicines and Healthcare products Regulatory Agency (“MHRA UK“) through the Innovative Licensing and Access Pathway (“ILAP“). TauRx was granted an Innovation Passport in May 2022, marking the first stage of the approval process, indicating MHRA UK’s recognition of the potential importance of this medication for Alzheimer’s Disease.

TauRx is also submitting the HMTM# results from LUCIDITY and earlier trials for regulatory approval in the USA. TauRx and Poredeen will be meeting and submitting data packages to other drug regulators in more territories, including the People’s Republic of China (“China“), soon."

<< Previous
Bullboard Posts
Next >>